Improved Overall Survival of Colorectal Cancer under Multidisciplinary Team: A Meta-Analysis

PURPOSE: The purpose of the current meta-analysis was to evaluate whether multidisciplinary team improved overall survival of colorectal cancer. METHODS: PubMed, EMBASE, and Cochrane Library database were searched from inception to October 25, 2020. The hazard ratio (HR) and 95% confidence (CI) of overall survival (OS) were calculated. RESULTS: A total of 11 studies with 30814 patients were included in this meta-analysis. After pooling the HRs, the MDT group was associated with better OS compared with the non-MDT group (HR = 0.81, 95% CI 0.69-0.94, p = 0.005). In subgroup analysis of stage IV colorectal cancer, the MDT group was associated with better OS as well (HR = 0.73, 95% CI 0.59-0.90, p = 0.004). However, in terms of postoperative mortality, no significant difference was found between MDT and non-MDT groups (OR = 0.84, 95% CI 0.44-1.61, p = 0.60). CONCLUSION: MDT could improve OS of colorectal cancer patients.